“Big Four” Pharmaceutical Pricing Boot Camp

Intensive training in the essential pricing concepts and methodologies related to VA, DoD, PHS, and Coast Guard programs

Tuesday, May 20, 2008

About

The U.S. government spends billions of dollars per year on the purchase of drugs making it one of the largest purchasers of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies.

Contents & Contributors

About

The U.S. government spends billions of dollars per year on the purchase of drugs making it one of the largest purchasers of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned contracting practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

This publication from ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies.

Contents & Contributors

KNOWING YOUR CUSTOMER: OVERVIEW OF THE “BIG FOUR” AND THEIR PHARMACEUTICAL RELATED PROGRAMS
Marcus Farbstein, Genentech

UNDERSTANDING THE VETERANS HEALTH CARE ACT (VHCA)
Donna Lee Yesner, Mckenna Long & Aldridge LLP
Jennifer Plitsch, Covington & Burling LLP

VHCA § 603: CALCULATING THE NON-FAMP AND THE FEDERAL CEILING PRICE (FCP)
Joy Sturm, Hogan & Hartson LLP
Marci Anderson, VA Office of Inspector General
Melbourne A. Noel, Jr., Department of Veterans Affairs

EXPLORING THE FEDERAL SUPPLY SCHEDULE
Maureen Regan, VA Office of Inspector General

VA MULTIPLE AWARD CONTRACTS
Larry Allen, Coalition for Government Procurement

INTERACTING WITH THE VA AND UNDERSTANDING THE AGENCY’S STRUCTURE
Marci Anderson, VA Office of Inspector General

EFFECTIVELY MANAGING NEGOTIATIONS WITH V.A.
William W. Goodrich, Jr., Arent Fox LLP

DETERMINING THE FSS PRICE: CONCEPTS AND CONSIDERATIONS IN GOVERNMENT FSS PROGRAMS
Marci Anderson, VA Office of Inspector General
Maureen Regan, VA Office of Inspector General
Stephen Ruscus, McKenna Long & Aldridge

SINGLE VERSUS DUAL PRICING
Marci Anderson, VA Office of Inspector General
Joy Sturm, Hogan & Hartson, LLP

PHARMACEUTICAL OPERATIONS DIRECTORATE VOLUNTARY AGREEMENTS FOR RETAIL REFUNDS
Lt. Col. Travis Watson, US Army

OVERVIEW OF THE DEPARTMENT OF DEFENSE (DOD) PHARMACY PROGRAM
Carol Cooper, TRICARE Management Activity

MANUFACTURER PERSPECTIVES ON TRICARE RETAIL PHARMACY REBATES
Constance A. Wilkinson, Epstein, Becker & Green, P.C.

340B PROGRAM FUNDAMENTALS
Marcus Farbstein, Genentech
Alice Valder Curran, Hogan & Hartson LLP
William von Oehsen, Safety Net Hospitals for Pharmaceutical Access

STRATEGIES FOR SECURING NATIONAL CONTRACTS AND BLANKET PURCHASE AGREEMENTS Larry Allen, Coalition for Government Procurement

“BIG FOUR” PHARMACEUTICAL PRICING BOOT CAMP BRIEFING
Steve Thomas, VA National Acquisition Center

AUDIT RIGHTS, RECORD RETENTION AND PENALTIES
T. Reed Stephens, McDermott Will & Emery LLC
Maureen Regan, VA Office of Inspector General



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0